Global Cardiac Marker Market Insights and Forecast to 2026
- BMR3911205
- 119 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Cardiac Marker was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Cardiac Marker is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Cardiac Marker market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cardiac Marker market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Cardiac Marker industry.
Global Cardiac Marker Scope and Segment
Cardiac Marker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cardiac Marker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
HyTest
Abbott
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific
Trinity Biotech
Sunfory
Lee BioSolutions
Cardiac Marker Breakdown Data by Type
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)
Cardiac Marker Breakdown Data by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Regional and Country-level Analysis
The Cardiac Marker market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cardiac Marker market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Cardiac Marker Market Share Analysis
1.1 Cardiac Marker Product Introduction
1.2 Market Segments
1.3 Key Cardiac Marker Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cardiac Marker Market Size Growth Rate by Type
1.4.2 Creatine kinase (CK) MB
1.4.3 Troponin (cTnI and cTnT)
1.4.4 BNP & NT-proBNP
1.4.5 Myogloblin
1.4.6 Others (hs-CRP, D-Dimer, etc.)
1.5 Market by Application
1.5.1 Global Cardiac Marker Market Size Growth Rate by Application
1.5.2 Myocardial Infarction
1.5.3 Congestive Heart Failure
1.5.4 Acute Coronary Syndrome
1.5.5 Atherosclerosis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cardiac Marker Market Size, Estimates and Forecasts
2.1.1 Global Cardiac Marker Revenue 2015-2026
2.1.2 Global Cardiac Marker Sales 2015-2026
2.2 Global Cardiac Marker, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cardiac Marker Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cardiac Marker Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cardiac Marker Competitor Landscape by Players
3.1 Cardiac Marker Sales by Manufacturers
3.1.1 Cardiac Marker Sales by Manufacturers (2015-2020)
3.1.2 Cardiac Marker Sales Market Share by Manufacturers (2015-2020)
3.2 Cardiac Marker Revenue by Manufacturers
3.2.1 Cardiac Marker Revenue by Manufacturers (2015-2020)
3.2.2 Cardiac Marker Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cardiac Marker Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cardiac Marker Revenue in 2019
3.2.5 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cardiac Marker Price by Manufacturers
3.4 Cardiac Marker Manufacturing Base Distribution, Product Types
3.4.1 Cardiac Marker Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cardiac Marker Product Type
3.4.3 Date of International Manufacturers Enter into Cardiac Marker Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cardiac Marker Market Size by Type (2015-2020)
4.1.1 Global Cardiac Marker Sales by Type (2015-2020)
4.1.2 Global Cardiac Marker Revenue by Type (2015-2020)
4.1.3 Cardiac Marker Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cardiac Marker Market Size Forecast by Type (2021-2026)
4.2.1 Global Cardiac Marker Sales Forecast by Type (2021-2026)
4.2.2 Global Cardiac Marker Revenue Forecast by Type (2021-2026)
4.2.3 Cardiac Marker Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cardiac Marker Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cardiac Marker Market Size by Application (2015-2020)
5.1.1 Global Cardiac Marker Sales by Application (2015-2020)
5.1.2 Global Cardiac Marker Revenue by Application (2015-2020)
5.1.3 Cardiac Marker Price by Application (2015-2020)
5.2 Cardiac Marker Market Size Forecast by Application (2021-2026)
5.2.1 Global Cardiac Marker Sales Forecast by Application (2021-2026)
5.2.2 Global Cardiac Marker Revenue Forecast by Application (2021-2026)
5.2.3 Global Cardiac Marker Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cardiac Marker by Country
6.1.1 North America Cardiac Marker Sales by Country
6.1.2 North America Cardiac Marker Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cardiac Marker Market Facts & Figures by Type
6.3 North America Cardiac Marker Market Facts & Figures by Application
7 Europe
7.1 Europe Cardiac Marker by Country
7.1.1 Europe Cardiac Marker Sales by Country
7.1.2 Europe Cardiac Marker Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cardiac Marker Market Facts & Figures by Type
7.3 Europe Cardiac Marker Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cardiac Marker by Region
8.1.1 Asia Pacific Cardiac Marker Sales by Region
8.1.2 Asia Pacific Cardiac Marker Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cardiac Marker Market Facts & Figures by Type
8.3 Asia Pacific Cardiac Marker Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cardiac Marker by Country
9.1.1 Latin America Cardiac Marker Sales by Country
9.1.2 Latin America Cardiac Marker Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cardiac Marker Market Facts & Figures by Type
9.3 Central & South America Cardiac Marker Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cardiac Marker by Country
10.1.1 Middle East and Africa Cardiac Marker Sales by Country
10.1.2 Middle East and Africa Cardiac Marker Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cardiac Marker Market Facts & Figures by Type
10.3 Middle East and Africa Cardiac Marker Market Facts & Figures by Application
11 Company Profiles
11.1 HyTest
11.1.1 HyTest Corporation Information
11.1.2 HyTest Description and Business Overview
11.1.3 HyTest Sales, Revenue and Gross Margin (2015-2020)
11.1.4 HyTest Cardiac Marker Products Offered
11.1.5 HyTest Related Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Description and Business Overview
11.2.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Cardiac Marker Products Offered
11.2.5 Abbott Related Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Corporation Information
11.3.2 Roche Diagnostics Description and Business Overview
11.3.3 Roche Diagnostics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Diagnostics Cardiac Marker Products Offered
11.3.5 Roche Diagnostics Related Developments
11.4 BG Medicine
11.4.1 BG Medicine Corporation Information
11.4.2 BG Medicine Description and Business Overview
11.4.3 BG Medicine Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BG Medicine Cardiac Marker Products Offered
11.4.5 BG Medicine Related Developments
11.5 Biomerieux
11.5.1 Biomerieux Corporation Information
11.5.2 Biomerieux Description and Business Overview
11.5.3 Biomerieux Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biomerieux Cardiac Marker Products Offered
11.5.5 Biomerieux Related Developments
11.6 Critical Diagnostics
11.6.1 Critical Diagnostics Corporation Information
11.6.2 Critical Diagnostics Description and Business Overview
11.6.3 Critical Diagnostics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Critical Diagnostics Cardiac Marker Products Offered
11.6.5 Critical Diagnostics Related Developments
11.7 DiaDexus
11.7.1 DiaDexus Corporation Information
11.7.2 DiaDexus Description and Business Overview
11.7.3 DiaDexus Sales, Revenue and Gross Margin (2015-2020)
11.7.4 DiaDexus Cardiac Marker Products Offered
11.7.5 DiaDexus Related Developments
11.8 Response Biomedical
11.8.1 Response Biomedical Corporation Information
11.8.2 Response Biomedical Description and Business Overview
11.8.3 Response Biomedical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Response Biomedical Cardiac Marker Products Offered
11.8.5 Response Biomedical Related Developments
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Corporation Information
11.9.2 Siemens Healthcare Description and Business Overview
11.9.3 Siemens Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Siemens Healthcare Cardiac Marker Products Offered
11.9.5 Siemens Healthcare Related Developments
11.10 Singulex
11.10.1 Singulex Corporation Information
11.10.2 Singulex Description and Business Overview
11.10.3 Singulex Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Singulex Cardiac Marker Products Offered
11.10.5 Singulex Related Developments
11.1 HyTest
11.1.1 HyTest Corporation Information
11.1.2 HyTest Description and Business Overview
11.1.3 HyTest Sales, Revenue and Gross Margin (2015-2020)
11.1.4 HyTest Cardiac Marker Products Offered
11.1.5 HyTest Related Developments
11.12 Trinity Biotech
11.12.1 Trinity Biotech Corporation Information
11.12.2 Trinity Biotech Description and Business Overview
11.12.3 Trinity Biotech Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Trinity Biotech Products Offered
11.12.5 Trinity Biotech Related Developments
11.13 Sunfory
11.13.1 Sunfory Corporation Information
11.13.2 Sunfory Description and Business Overview
11.13.3 Sunfory Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sunfory Products Offered
11.13.5 Sunfory Related Developments
11.14 Lee BioSolutions
11.14.1 Lee BioSolutions Corporation Information
11.14.2 Lee BioSolutions Description and Business Overview
11.14.3 Lee BioSolutions Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Lee BioSolutions Products Offered
11.14.5 Lee BioSolutions Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cardiac Marker Market Estimates and Projections by Region
12.1.1 Global Cardiac Marker Sales Forecast by Regions 2021-2026
12.1.2 Global Cardiac Marker Revenue Forecast by Regions 2021-2026
12.2 North America Cardiac Marker Market Size Forecast (2021-2026)
12.2.1 North America: Cardiac Marker Sales Forecast (2021-2026)
12.2.2 North America: Cardiac Marker Revenue Forecast (2021-2026)
12.2.3 North America: Cardiac Marker Market Size Forecast by Country (2021-2026)
12.3 Europe Cardiac Marker Market Size Forecast (2021-2026)
12.3.1 Europe: Cardiac Marker Sales Forecast (2021-2026)
12.3.2 Europe: Cardiac Marker Revenue Forecast (2021-2026)
12.3.3 Europe: Cardiac Marker Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cardiac Marker Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cardiac Marker Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cardiac Marker Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cardiac Marker Market Size Forecast by Region (2021-2026)
12.5 Latin America Cardiac Marker Market Size Forecast (2021-2026)
12.5.1 Latin America: Cardiac Marker Sales Forecast (2021-2026)
12.5.2 Latin America: Cardiac Marker Revenue Forecast (2021-2026)
12.5.3 Latin America: Cardiac Marker Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cardiac Marker Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cardiac Marker Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cardiac Marker Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cardiac Marker Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Cardiac Marker Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cardiac Marker Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cardiac Marker Market Segments
Table 2. Ranking of Global Top Cardiac Marker Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cardiac Marker Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Creatine kinase (CK) MB
Table 5. Major Manufacturers of Troponin (cTnI and cTnT)
Table 6. Major Manufacturers of BNP & NT-proBNP
Table 7. Major Manufacturers of Myogloblin
Table 8. Major Manufacturers of Others (hs-CRP, D-Dimer, etc.)
Table 9. Global Cardiac Marker Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 10. Global Cardiac Marker Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 11. Global Cardiac Marker Sales by Regions 2015-2020 (K Doses)
Table 12. Global Cardiac Marker Sales Market Share by Regions (2015-2020)
Table 13. Global Cardiac Marker Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Cardiac Marker Sales by Manufacturers (2015-2020) (K Doses)
Table 15. Global Cardiac Marker Sales Share by Manufacturers (2015-2020)
Table 16. Global Cardiac Marker Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Cardiac Marker by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cardiac Marker as of 2019)
Table 18. Cardiac Marker Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Cardiac Marker Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Cardiac Marker Price (2015-2020) (USD/Dose)
Table 21. Cardiac Marker Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Cardiac Marker Product Type
Table 23. Date of International Manufacturers Enter into Cardiac Marker Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Cardiac Marker Sales by Type (2015-2020) (K Doses)
Table 26. Global Cardiac Marker Sales Share by Type (2015-2020)
Table 27. Global Cardiac Marker Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Cardiac Marker Revenue Share by Type (2015-2020)
Table 29. Cardiac Marker Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 30. Global Cardiac Marker Sales by Application (2015-2020) (K Doses)
Table 31. Global Cardiac Marker Sales Share by Application (2015-2020)
Table 32. North America Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 33. North America Cardiac Marker Sales Market Share by Country (2015-2020)
Table 34. North America Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 36. North America Cardiac Marker Sales by Type (2015-2020) (K Doses)
Table 37. North America Cardiac Marker Sales Market Share by Type (2015-2020)
Table 38. North America Cardiac Marker Sales by Application (2015-2020) (K Doses)
Table 39. North America Cardiac Marker Sales Market Share by Application (2015-2020)
Table 40. Europe Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 41. Europe Cardiac Marker Sales Market Share by Country (2015-2020)
Table 42. Europe Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 44. Europe Cardiac Marker Sales by Type (2015-2020) (K Doses)
Table 45. Europe Cardiac Marker Sales Market Share by Type (2015-2020)
Table 46. Europe Cardiac Marker Sales by Application (2015-2020) (K Doses)
Table 47. Europe Cardiac Marker Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Cardiac Marker Sales by Region (2015-2020) (K Doses)
Table 49. Asia Pacific Cardiac Marker Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Cardiac Marker Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Cardiac Marker Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Cardiac Marker Sales by Type (2015-2020) (K Doses)
Table 53. Asia Pacific Cardiac Marker Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Cardiac Marker Sales by Application (2015-2020) (K Doses)
Table 55. Asia Pacific Cardiac Marker Sales Market Share by Application (2015-2020)
Table 56. Latin America Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 57. Latin America Cardiac Marker Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 60. Latin America Cardiac Marker Sales by Type (2015-2020) (K Doses)
Table 61. Latin America Cardiac Marker Sales Market Share by Type (2015-2020)
Table 62. Latin America Cardiac Marker Sales by Application (2015-2020) (K Doses)
Table 63. Latin America Cardiac Marker Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Cardiac Marker Sales by Country (2015-2020) (K Doses)
Table 65. Middle East and Africa Cardiac Marker Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Cardiac Marker Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Cardiac Marker Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Cardiac Marker Sales by Type (2015-2020) (K Doses)
Table 69. Middle East and Africa Cardiac Marker Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Cardiac Marker Sales by Application (2015-2020) (K Doses)
Table 71. Middle East and Africa Cardiac Marker Sales Market Share by Application (2015-2020)
Table 72. HyTest Corporation Information
Table 73. HyTest Description and Major Businesses
Table 74. HyTest Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 75. HyTest Product
Table 76. HyTest Recent Development
Table 77. Abbott Corporation Information
Table 78. Abbott Description and Major Businesses
Table 79. Abbott Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 80. Abbott Product
Table 81. Abbott Recent Development
Table 82. Roche Diagnostics Corporation Information
Table 83. Roche Diagnostics Description and Major Businesses
Table 84. Roche Diagnostics Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 85. Roche Diagnostics Product
Table 86. Roche Diagnostics Recent Development
Table 87. BG Medicine Corporation Information
Table 88. BG Medicine Description and Major Businesses
Table 89. BG Medicine Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 90. BG Medicine Product
Table 91. BG Medicine Recent Development
Table 92. Biomerieux Corporation Information
Table 93. Biomerieux Description and Major Businesses
Table 94. Biomerieux Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 95. Biomerieux Product
Table 96. Biomerieux Recent Development
Table 97. Critical Diagnostics Corporation Information
Table 98. Critical Diagnostics Description and Major Businesses
Table 99. Critical Diagnostics Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 100. Critical Diagnostics Product
Table 101. Critical Diagnostics Recent Development
Table 102. DiaDexus Corporation Information
Table 103. DiaDexus Description and Major Businesses
Table 104. DiaDexus Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 105. DiaDexus Product
Table 106. DiaDexus Recent Development
Table 107. Response Biomedical Corporation Information
Table 108. Response Biomedical Description and Major Businesses
Table 109. Response Biomedical Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 110. Response Biomedical Product
Table 111. Response Biomedical Recent Development
Table 112. Siemens Healthcare Corporation Information
Table 113. Siemens Healthcare Description and Major Businesses
Table 114. Siemens Healthcare Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 115. Siemens Healthcare Product
Table 116. Siemens Healthcare Recent Development
Table 117. Singulex Corporation Information
Table 118. Singulex Description and Major Businesses
Table 119. Singulex Cardiac Marker Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 120. Singulex Product
Table 121. Singulex Recent Development
Table 122. Thermo Scientific Corporation Information
Table 123. Thermo Scientific Description and Major Businesses
Table 124. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 125. Thermo Scientific Product
Table 126. Thermo Scientific Recent Development
Table 127. Trinity Biotech Corporation Information
Table 128. Trinity Biotech Description and Major Businesses
Table 129. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 130. Trinity Biotech Product
Table 131. Trinity Biotech Recent Development
Table 132. Sunfory Corporation Information
Table 133. Sunfory Description and Major Businesses
Table 134. Sunfory Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 135. Sunfory Product
Table 136. Sunfory Recent Development
Table 137. Lee BioSolutions Corporation Information
Table 138. Lee BioSolutions Description and Major Businesses
Table 139. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 140. Lee BioSolutions Product
Table 141. Lee BioSolutions Recent Development
Table 142. Global Cardiac Marker Sales Forecast by Regions (2021-2026) (K Doses)
Table 143. Global Cardiac Marker Sales Market Share Forecast by Regions (2021-2026)
Table 144. Global Cardiac Marker Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 145. Global Cardiac Marker Revenue Market Share Forecast by Regions (2021-2026)
Table 146. North America: Cardiac Marker Sales Forecast by Country (2021-2026) (K Doses)
Table 147. North America: Cardiac Marker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Europe: Cardiac Marker Sales Forecast by Country (2021-2026) (K Doses)
Table 149. Europe: Cardiac Marker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Asia Pacific: Cardiac Marker Sales Forecast by Region (2021-2026) (K Doses)
Table 151. Asia Pacific: Cardiac Marker Revenue Forecast by Region (2021-2026) (US$ Million)
Table 152. Latin America: Cardiac Marker Sales Forecast by Country (2021-2026) (K Doses)
Table 153. Latin America: Cardiac Marker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Middle East and Africa: Cardiac Marker Sales Forecast by Country (2021-2026) (K Doses)
Table 155. Middle East and Africa: Cardiac Marker Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key Cardiac Marker Players
Table 160. Cardiac Marker Customers List
Table 161. Cardiac Marker Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Cardiac Marker Product Picture
Figure 2. Global Cardiac Marker Sales Market Share by Type in 2020 & 2026
Figure 3. Creatine kinase (CK) MB Product Picture
Figure 4. Troponin (cTnI and cTnT) Product Picture
Figure 5. BNP & NT-proBNP Product Picture
Figure 6. Myogloblin Product Picture
Figure 7. Others (hs-CRP, D-Dimer, etc.) Product Picture
Figure 8. Global Cardiac Marker Sales Market Share by Application in 2020 & 2026
Figure 9. Myocardial Infarction
Figure 10. Congestive Heart Failure
Figure 11. Acute Coronary Syndrome
Figure 12. Atherosclerosis
Figure 13. Others
Figure 14. Cardiac Marker Report Years Considered
Figure 15. Global Cardiac Marker Market Size 2015-2026 (US$ Million)
Figure 16. Global Cardiac Marker Sales 2015-2026 (K Doses)
Figure 17. Global Cardiac Marker Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Cardiac Marker Sales Market Share by Region (2015-2020)
Figure 19. Global Cardiac Marker Sales Market Share by Region in 2019
Figure 20. Global Cardiac Marker Revenue Market Share by Region (2015-2020)
Figure 21. Global Cardiac Marker Revenue Market Share by Region in 2019
Figure 22. Global Cardiac Marker Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Cardiac Marker Revenue in 2019
Figure 24. Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Cardiac Marker Sales Market Share by Type (2015-2020)
Figure 26. Global Cardiac Marker Sales Market Share by Type in 2019
Figure 27. Global Cardiac Marker Revenue Market Share by Type (2015-2020)
Figure 28. Global Cardiac Marker Revenue Market Share by Type in 2019
Figure 29. Global Cardiac Marker Market Share by Price Range (2015-2020)
Figure 30. Global Cardiac Marker Sales Market Share by Application (2015-2020)
Figure 31. Global Cardiac Marker Sales Market Share by Application in 2019
Figure 32. Global Cardiac Marker Revenue Market Share by Application (2015-2020)
Figure 33. Global Cardiac Marker Revenue Market Share by Application in 2019
Figure 34. North America Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 35. North America Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Cardiac Marker Sales Market Share by Country in 2019
Figure 37. North America Cardiac Marker Revenue Market Share by Country in 2019
Figure 38. U.S. Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 39. U.S. Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 41. Canada Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Cardiac Marker Market Share by Type in 2019
Figure 43. North America Cardiac Marker Market Share by Application in 2019
Figure 44. Europe Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 45. Europe Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Cardiac Marker Sales Market Share by Country in 2019
Figure 47. Europe Cardiac Marker Revenue Market Share by Country in 2019
Figure 48. Germany Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Germany Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 51. France Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 53. U.K. Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 55. Italy Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Russia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Cardiac Marker Market Share by Type in 2019
Figure 59. Europe Cardiac Marker Market Share by Application in 2019
Figure 60. Asia Pacific Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 61. Asia Pacific Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Cardiac Marker Sales Market Share by Region in 2019
Figure 63. Asia Pacific Cardiac Marker Revenue Market Share by Region in 2019
Figure 64. China Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 65. China Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Japan Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 69. South Korea Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 71. India Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Australia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Taiwan Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Indonesia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Thailand Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Malaysia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Philippines Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 85. Vietnam Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Cardiac Marker Market Share by Type in 2019
Figure 87. Asia Pacific Cardiac Marker Market Share by Application in 2019
Figure 88. Latin America Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 89. Latin America Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Cardiac Marker Sales Market Share by Country in 2019
Figure 91. Latin America Cardiac Marker Revenue Market Share by Country in 2019
Figure 92. Mexico Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Mexico Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 95. Brazil Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 97. Argentina Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Cardiac Marker Market Share by Type in 2019
Figure 99. Latin America Cardiac Marker Market Share by Application in 2019
Figure 100. Middle East and Africa Cardiac Marker Sales Growth Rate 2015-2020 (K Doses)
Figure 101. Middle East and Africa Cardiac Marker Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Cardiac Marker Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Cardiac Marker Revenue Market Share by Country in 2019
Figure 104. Turkey Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 105. Turkey Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 107. Saudi Arabia Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Cardiac Marker Sales Growth Rate (2015-2020) (K Doses)
Figure 109. U.A.E Cardiac Marker Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Cardiac Marker Market Share by Type in 2019
Figure 111. Middle East and Africa Cardiac Marker Market Share by Application in 2019
Figure 112. North America Cardiac Marker Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. North America Cardiac Marker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Cardiac Marker Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Europe Cardiac Marker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Cardiac Marker Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Asia Pacific Cardiac Marker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Cardiac Marker Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 119. Latin America Cardiac Marker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Cardiac Marker Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 121. Middle East and Africa Cardiac Marker Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
